Waverly Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Waverly Advisors's AZN Position: Q3 2026 in Review
Waverly Advisors increased its AstraZeneca (AZN) stake by 2.4% in Q3 2026, buying an estimated $471K and bringing the position to 122,057 shares worth $19.7M. The position accounts for 0.11% of the portfolio, ranked #174.
Waverly Advisors first reported a position in AZN in Q4 2013 and has held it in 18 quarters since. The position peaked at $23.4M in Q1 2026. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Waverly Advisors held 122,057 shares of AstraZeneca worth $19.7M as of Q3 2026.
- Waverly Advisors bought 2,824 AstraZeneca shares in Q3 2026, an estimated $471K.
- AstraZeneca made up 0.11% of Waverly Advisors's portfolio in Q3 2026, its #174 holding.
- Waverly Advisors first reported a position in AstraZeneca in Q4 2013 and has held it in 18 quarters since.
- Waverly Advisors's AstraZeneca position peaked at $23.4M in Q1 2026.
- 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Waverly Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.